Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer.
about
Profile of nintedanib in the treatment of solid tumors: the evidence to datePersistent androgen receptor addiction in castration-resistant prostate cancerRisk of selected gastrointestinal and hepatic toxicities in cancer patients treated with nintedanib: a meta-analysis.Afatinib reverses multidrug resistance in ovarian cancer via dually inhibiting ATP binding cassette subfamily B member 1.Phase I study of afatinib combined with nintedanib in patients with advanced solid tumours.A Phase I dose-escalation study of afatinib combined with nintedanib in patients with advanced solid tumors.Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype.Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP)Discovering drugs to overcome chemoresistance in ovarian cancers based on the cancer genome atlas tumor transcriptome profile.Nintedanib in ovarian cancer.Nintedanib: first global approval.
P2860
Q26775134-966CE931-ABAA-49DC-8920-7A8D4FC84EF6Q26777163-50F4816B-60BF-4917-852B-B1ECA61FC844Q30249619-919C2A4A-8F6A-4086-AF73-A9685B03EBB1Q36413392-1D0417BA-25B8-47A6-9139-6C48B159E5B6Q36750974-FE7C8D99-77C9-4DC7-9C21-212927637580Q39008385-C35DD395-CCED-4322-9C7B-767A57A4EBF3Q41070558-DE5859FD-FA30-4714-9EAE-9D6A7FEC6366Q42240146-65C08890-C2A0-4EFD-9A50-C302A959D2ADQ49220207-3F2970A3-4F88-46DC-913B-38F9490EE3D4Q51824301-31269204-7757-4CCA-AFF7-3388CAF6E23DQ54307476-FD4E7852-DBA2-4E66-A230-6AD137512E82
P2860
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Randomized Phase II trial of n ...... ion-resistant prostate cancer.
@en
Randomized Phase II trial of n ...... ion-resistant prostate cancer.
@nl
type
label
Randomized Phase II trial of n ...... ion-resistant prostate cancer.
@en
Randomized Phase II trial of n ...... ion-resistant prostate cancer.
@nl
prefLabel
Randomized Phase II trial of n ...... ion-resistant prostate cancer.
@en
Randomized Phase II trial of n ...... ion-resistant prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
Randomized Phase II trial of n ...... ion-resistant prostate cancer.
@en
P2093
Aurelius Omlin
Catherine Heath
David Bloomfield
David Olmos
Duncan Wheatley
Emilda Thompson
Graeme Lumsden
Graham Temple
Ian Pedley
Joe M O'Sullivan
P2860
P304
P356
10.2217/FON.13.250
P407
P577
2014-02-01T00:00:00Z